molecular genetic, and transgenic methods and technologies. The institute participates in the following study programs: BSc Biology, Leibniz-University Hannover MSc Biomedicine, Hannover Medical School MSc B
extracellular matrix remodeling (MMP-9 biosensor, shedding reporters) Biochemical approaches to study: pathological protein aggregation post-translational modifications (in particular palmitoylation)
Stiel S. Long-distance caregiving at the end of life: A protocol for an exploratory qualitative study in Germany. BMC Palliat Care. 2022; 21: 69 (BMC Pall Care) Herbst FA, Schneider N, Stiel S. Recom [...] 2022; 1: 20–21 (Angehörige pflegen) Herbst FA, Stiel S. “Has Anyone Been There Now?”: An Interview Study on the Support Experiences and Unmet Needs of Informal Long-Distance Caregivers for Patients at the
functional mouse model with a human immune system and human liver cells for the study of HCV pathogenesis and therapy; study of the functional ability of bone marrow derived stem cells in the repair of
(Bundesverband der pharmazeutischen Industrie), BÄK (Bundesärztekammer), BUVEBA (Bundesverband der Study Nurses//Studienassistenten in der klin. Forschung e.V.), BVMA (Bundesverband Medizinischer Auftra
A, Busche T, Egen C . Feasibility study of an experimental social space-oriented rehabilitation concept for people with intellectual and/or multiple disabilies: a study protocol. BMJ Open 2025; 15:e085390 [...] anxiety, and quality of life in patients with frequent tension-type headache: A randomized controlled study. Cephalalgie 2023; 43(1): DOI: https://doi.org/10.1177/03331024221132800 Egen C , Schiller J, Gutenbrunner [...] (QoL) of people with acquired Spinal Cord Injury (SCI)? A cross-sectional explorative observational study. Spinal Cord 2021; DOI: https://doi.org/10.1038/s41393-021-00663-z Gutenbrunner C, Briest J, Egen
Jessica Kaufeld (oberärztliche Leitung Studienzentrum) Elisabeth Bahlmann-Kroll (Studienkoordinatorin) Study nurse Constanze Alexa Kontakt Telefon 0511-532 3000 Telefax 0511-532 9358 E-Mail studienzentrum@m
Mark-Christian Jaboreck (AG Martin): “Development of a hiPSC-based cystic fibrosis lung disease model to study TMEM16A as an alternative therapeutic target in cystic fibrosis” Mikhail Magdei (AG Hilfiker): “Analysis
prior infection or vaccination, requiring vaccine adaptation. Within the frame of the ongoing CoCo Study, we analyzed the immunogenicity of an adapted vaccine, BNT162b2 Omicron XBB.1.5, which is currently
3705 Fax: +49 511 532 5966 E-mail: fedorov.roman @ mh-hannover.de Research Focus In our group, we study allosteric mechanisms that regulate enzymatic catalysis in the vital biological processes with the